The abstract is read at the publisher; the summary is JClub's.
Mathematical modeling frameworks spanning ODE, agent-based, statistical, and machine learning approaches are organized to address translational challenges in CAR T cell therapy, highlighting key data gaps.
- Why it matters: CAR T therapy still shows variable responses, relapse, and safety issues, and experimental optimization of regimens and genetic designs is constrained by an overly large design space.
- What they did: The perspective evaluates modeling methods across mechanistic and predictive goals, mapping strengths, limitations, and missing data, and proposes a roadmap for clinicians and modelers.
- The result: It frames emerging opportunities—especially machine learning, multiscale modeling, control theory, and alternative cell types—to support model-guided design of next-generation cell therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.